Cosmederm Bioscience, Inc.
Records under this name other than the patents Cosmederm Bioscience, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Back to Cosmederm Bioscience, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,333,185 | Topically administered strontium-containing complexes for treating pain, pruritis and inflammation Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,480,704 | Topically administered strontium-containing complexes for treating pain, pruritis and inflammation Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,801,261 | Topically administered strontium-containing complexes for treating pain, pruritis and inflammation Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,235,002 | Strontium Based Compositions and Formulations for Pain, Pruritus, and Inflammation Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 12,121,536 | Strontium Based Compositions and Formulations for Pain, Pruritus, and Inflammation Formerly held In force · Low confidence | In force | Low confidence | |
| US 6,139,850 | Formulations and methods for reducing skin irritation Formerly held Term ended Term ended Jun 23, 2017 · From the USPTO record | Term ended | Term ended Jun 23, 2017 | From the USPTO record |
| US 6,455,076 | Formulations and methods for reducing skin irritation Formerly held Term ended Term ended Jun 23, 2017 · From the USPTO record | Term ended | Term ended Jun 23, 2017 | From the USPTO record |
| US 7,404,967 | Topical product formulations containing strontium for reducing skin irritation Formerly held Term ended Ended no later than Dec 21, 2014 · From the USPTO record | Term ended | Ended no later than Dec 21, 2014 | From the USPTO record |
| US 8,147,855 | Methods for inhibiting sensory responses in the skin such as pain and itch using topical product formulations containing strontium Formerly held Term ended Ended no later than Dec 21, 2014 · From the USPTO record | Term ended | Ended no later than Dec 21, 2014 | From the USPTO record |
| US 8,449,923 | Methods for inhibiting sensory nerves by topically administering strontium-containing compositions to keratinized skin Formerly held Term ended Ended no later than Dec 21, 2014 · From the USPTO record | Term ended | Ended no later than Dec 21, 2014 | From the USPTO record |